Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
REVENUES        
Government contract revenue $ 624,871 $ 413,458 $ 624,871 $ 443,458
OPERATING EXPENSES        
Professional fees 624,979 609,933 1,845,659 1,979,848
Payroll and related expenses 1,523,650 406,421 2,520,805 1,609,942
General and administrative 919,830 273,510 1,883,802 998,465
Total operating expenses 3,068,459 1,289,864 6,250,266 4,588,255
OPERATING LOSS (2,443,588) (876,406) (5,625,395) (4,144,797)
OTHER EXPENSE        
Interest and other debt expenses 802 126 1,530 54,232
(Gain) on share for warrant exchanges 0 (55,593) 0 (51,190)
Loss on debt extinguishment 0 0 0 447,011
Total other expense 802 (55,467) 1,530 450,053
NET LOSS (2,444,390) (820,939) (5,626,925) (4,594,850)
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS (1,498) (1,358) (3,186) (3,808)
NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. $ (2,442,892) $ (819,581) $ (5,623,739) $ (4,591,042)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (0.20) $ (0.28) $ (0.50) $ (2.52)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED 12,093,361 2,887,883 11,265,725 1,821,557